Business Context and Reporting Period
Company: iSpecimen Inc. (Nasdaq: ISPC)
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2025
Event: Entry into a Material Definitive Agreement for a private placement of equity securities.
Key Financial Metrics and Transaction Details
- Securities Issued: 6,875 shares of newly-designated Series C Convertible Non-Voting Preferred Stock.
- Aggregate Proceeds: $5.5 million.
- Purchase Price: $800 per share (Stated value: $1,000 per share).
- Closing Date: December 31, 2025.
- Placement Agent: E.F. Hutton & Co.
- Conversion Terms: Convertible into Common Stock at a price equal to 85% of the closing price of Common Stock on the trading day preceding conversion, subject to a floor price of $0.0681.
Material Changes and Agreements
The Company entered into three primary agreements on December 30, 2025:
- Securities Purchase Agreement: Governs the sale of Series C Preferred Stock to accredited investors.
- Registration Rights Agreement: Grants investors rights to require the Company to file a registration statement for the resale of Conversion Shares.
- Placement Agent Agreement: Appoints E.F. Hutton & Co. as the exclusive placement agent.
Corporate Governance Change: The Company filed a Certificate of Designation with the Delaware Secretary of State. The Series C Preferred Stock ranks senior to Common Stock regarding dividends and liquidation but carries no voting rights. However, holders possess protective provisions requiring their affirmative vote for certain amendments to charter documents or adverse changes to their rights.
Guidance, Risks, and Unusual Items
- Regulatory Status: The issuance was made in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D as a transaction not involving a public offering.
- Dilution Risk: Future conversion of the Series C Preferred Stock will result in the issuance of Common Stock, subject to the variable conversion price and floor price.
- Management Commentary: The filing text does not provide specific management commentary, forward-looking guidance, or risk factors beyond the standard legal descriptions of the agreements.
Investor Verification Checklist
- Verify the exact number of Common Shares issuable upon conversion based on the current market price and the $0.0681 floor price.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions imposed on the Company.
- Confirm the timeline for the filing of the initial registration statement as required by the Registration Rights Agreement (Exhibit 10.2).
- Assess the impact of the $5.5 million cash inflow on the Company's current liquidity position and runway.